Funded Tech Companies

Degron Therapeutics

Degron Therapeutics is a leading biopharmaceutical tech company, based in San Diego. Venture investment and financing was provided by Fortune China Limited, Kinghall Ventures and Lapam Capital.

Company Overview

Contact Information

Company Background Information

Overview

Degron Therapeutics aims to become a global leader in the discovery and development of a new class of targeted protein degradation therapeutics, small molecule molecular glue degrader (MGD) drugs. Degron has assembled a team of world-class executives and scientific leaders, bringing its scientific excellence to the identification and validation of disease targets, particularly those undruggable by conventional small molecule inhibitors, and novel selective MGD compounds to meet unmet medical needs in all therapeutic areas.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/15/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Lily Zou

        

Chief Scientific Officer

Yong Cang

        

Company Investors

• Fortune China Limited
• Kinghall Ventures
• Lapam Capital
• Baidu Venture Capital
• Cowin Venture Capital
• Dyee Capital
• Med-Fine Capital (Jing Yu)
• NeuX Capital
• Yuanbio Venture Capital

Browse more funded tech companies:

Degreed | DeHaat

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary